Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Clinical trial NCT07671092 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07671092
Sponsor: RayzeBio, Inc.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma Breast Cancer TNBC - Triple-Negative Breast Cancer Hormone Receptor Positive HER-2 Negative Breast Cancer NSCLC

Start date: 2026-06-01
Primary completion: 2027-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.